BNP predicted progressive heart failure death while endothelin better predicted sudden cardiac death in chronic heart failure, enabling mode-of-death-specific risk stratification for targeted prevention.
Key findingNT-proBNP was the strongest predictor of progressive heart failure death, while endothelin-1 and norepinephrine better predicted sudden cardiac death
What the researchers found
NT-proBNP was the strongest predictor of progressive heart failure death, while endothelin-1 and norepinephrine better predicted sudden cardiac death — different neurohormones predict different death modes, enabling targeted prevention strategies (ICD vs medical intensification).
Why it matters
Relevant for natriuretic-peptides, cardiovascular, clinical-trials.
How the study worked
cohort study on natriuretic-peptides, cardiovascular.
What this study cannot tell us
See abstract.
How to read the evidence
strong evidence.
When this study was published
Published in 2005.
The bigger picture
Advances peptide research with translational implications.
Questions still open
- Further research needed.
- Clinical translation to evaluate.
Common questions
What was studied?
What was found?
Read the original research
Neurohormonal risk stratification for sudden death and death owing to progressive heart failure in chronic heart failure.
European journal of clinical investigation, 35(1), 24-31
Citation
Berger, R; Huelsmann, M; Strecker, K; Moertl, D; Moser, P; Bojic, A; Pacher, R. (2005). Neurohormonal risk stratification for sudden death and death owing to progressive heart failure in chronic heart failure.. European journal of clinical investigation, 35(1), 24-31.